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Summary
 
Airway inflammation plays a central role in the pathogenesis of asthma. However, the precise
contribution of all cell types in the development and maintenance of airway hyperreactivity
and histopathology during allergic inflammation remains unclear. After sensitization of mice in
the periphery, challenge by multiple intratracheal (i.t.) instillations of ovalbumin (OVA) results
in eosinophilia, mononuclear cell infiltration, and airway epithelial changes analogous to that
seen in asthma (Blyth, D.I., M.S. Pedrick, T.J. Savage, E.M. Hessel, and D. Fattah. 1996. 
 
Am.
J. Respir. Cell Mol. Biol
 
. 14:425–438). To investigate further the nature of the cellular infiltrate,
lungs from OVA-versus saline-treated mice were processed for histology and immunohis-
tochemistry. One of the most striking features observed was the formation of germinal centers
within the parenchyma of the inflamed lungs. In addition, follicular dendritic cells (FDCs) bearing
OVA on their plasma membranes appeared and, adjacent to these sites, OVA-specific IgG1-,
IgE-, and IgA-producing plasma cells emerged. To confirm that antigen-specific immunoglob-
ulins (Ig) were being produced within the parenchyma, plasma cell number and antibody pro-
duction were quantitated in vitro after isolation of cells from the lung. These assays confirmed
that the isotypes observed in situ were a secreted product. As IgE-dependent mechanisms have
been implicated as being central to the pathogenesis of bronchial asthma, airway hyperrespon-
siveness was evaluated. The mice undergoing lung inflammation were hyperresponsive, while
the control group remained at baseline. These data demonstrate that antigen-driven differentia-
tion of B cells via induction of an FDC network and germinal centers occurs in the paren-
chyma of inflamed lungs. These germinal centers would then provide a local source of IgE-
secreting plasma cells that contribute to the release of factors mediating inflammatory processes
in the lung.
 
G
 
erminal centers are unique microenvironments in
which affinity maturation of the antibody response
occurs (2, 3). In addition, in these sites, Ig rearrangement of
heavy chains is facilitated, resulting in the production of
switched Ig isotypes (4, 5). B cells that exit the germinal
center response are either preplasma cells that finish their
differentiation elsewhere or memory cell clones (6, 7).
Germinal center reactions are usually studied within sec-
ondary lymphoid tissues such as tonsils, lymph nodes, and
spleens. However, an extensive network of lymphoid tissue
can also be observed along the digestive and respiratory
tract, referred to as gut-associated lymphoid tissue (GALT
 
1
 
,
which includes the Peyer’s patches) and bronchus-associ-
ated lymphoid tissue (BALT; 8). BALT consists of follicular
aggregates of lymphocytes in which high endothelial venules
are present (9). These are constitutive structures in certain
species, such as rats and rabbits (10). However, in other
species such as humans and pigs, the development of BALT
appears to be dependent on antigenic challenges such as
bacterial infections (11–13). The role of germinal centers in
BALT during inflammatory conditions as a protective ver-
sus pathogenic entity remains to be determined.
One of the key elements in experimental models of al-
lergy and asthma is IgE (14). Mast cells, monocytes, mac-
rophages, eosinophils, basophils, and bronchopulmonary
dendritic cells are induced to mediate mechanisms of in-
flammation via the high affinity receptor for IgE (15, 16).
In sensitized individuals, both blood serum and lung lavage
fluids contain large quantities of allergen-specific IgE (17-19).
 
1
 
Abbreviations used in this paper: 
 
PNA, peanut agglutinin; FDC, follicular
dendritic cell; GALT, gut-associated lymphoid tissue; BALT, bronchus-
associated lymphoid tissue; i.t., intratracheal; Penh, enhanced pause.
 
Y. Chvatchko and M. Kosco-Vilbois contributed equally to this work.
  
2354
 
Germinal Centers and IgE Production in the Lung
 
Although the source of these antibodies is assumed to be
generated solely in lymph nodes draining the lung, large
numbers of cells also infiltrate the parenchyma (20).
In an attempt to define further the nature of these cellu-
lar infiltrates and determine whether a local source of IgE is
produced, a mouse model of allergic pulmonary inflamma-
tion was employed. Mice primed parenterally with OVA in
the absence of adjuvant were then intratracheally (i.t.) chal-
lenged with saline or OVA (20a). 3 d after the final i.t.
provocation, blood serum Ig levels were quantitated and
the histological changes within the lungs evaluated. The re-
sults demonstrate that germinal centers within BALT arise
after exposure to airway antigen. Furthermore, antigen-
specific IgE-secreting plasma cells were detected in the ad-
jacent infiltrate. Local germinal center reactions via the
ability to induce antigen-specific IgE-secreting preplasma
cells may then contribute ultimately to the pathology of al-
lergic asthma.
 
Materials and Methods
 
Sensitization and Intratracheal Challenge with Ovalbumin.
 
Sensi-
tization was performed using the method of Hessel and colleagues
(21). 8-wk-old female BALB/c mice (Centre d’Elevage Janvier,
Le Genest Saint-Isle, France) were immunized by either i.p. or
s.c. injections of 10 
 
m
 
g OVA (A-5503, Sigma Chemical Corp.,
St. Louis, MO) in 0.1 ml NaCl (0.9% wt/vol) every other day for
14 d. Sham-sensitized mice received 0.1 ml of NaCl using the
same protocol.
On day 40 after the beginning of parenteral sensitization, mice
were challenged by i.t. instillation of OVA. For this, mice were
anesthetized i.p. with 0.2 ml of Saffan anesthesia (Vet Drug, Ltd.,
Dunnington, York, UK), OVA (20 
 
m
 
g in 10 
 
m
 
l saline) was deliv-
ered i.t. using the method of Ho and Furst (22). Sham-challenged
mice received 10 
 
m
 
l saline. A second control group involved
challenging the OVA-sensitized mice with saline. The effects of
treatment were studied after three challenges, each 3 d apart. 3 d
after the final provocation, groups of mice were killed and lungs
processed for the various assays.
 
Measurement of OVA-specific Serum and Supernatant Igs.
 
OVA-
specific IgE, IgG1, IgG2a, and IgG2b antibody titers were mea-
sured in the serum samples obtained 3 d after the final i.t. treat-
ment using a standard ELISA protocol. In addition, supernatants
from the culture of cells isolated to determine the number of an-
tibody-producing cells present in the lung were also tested (see
Isolation of Lung Cells). For the ELISAs, 96-well microtiter
plates (Maxisorp; Nunc Life Technologies, Basel, Switzerland)
were coated with OVA (20 
 
m
 
g/ml; diluted in NaHCO
 
3
 
 buffer,
pH 9.6). After overnight incubation at 4
 
8
 
C, plates were washed
and blocked with PBS containing 10% FCS for 30 min at room
temperature. Serum samples were diluted in blocking buffer.
Twofold serial dilutions were prepared and incubated overnight
at 4
 
8
 
C. After washing, either peroxidase-conjugated polyclonal
sheep anti–mouse IgG1, IgG2a, or IgG2b (Binding Site, Bir-
mingham, UK) or a monoclonal rat anti–mouse IgE, EM95 (23),
diluted in PBS containing 0.1% Tween buffer were added for an
additional 1 h. The rat anti–mouse IgE, EM95, was followed by a
peroxidase-conjugated mouse anti–rat IgG (Jackson Immunore-
search Laboratories, West Grove, PA). The reaction was devel-
oped and the plates read with a microplate autoreader (MR 5000;
Dynatech, Embrach-Embraport, Switzerland).
 
Evaluation of Allergen-induced Airway Hyperresponsiveness.
 
Air-
way responsiveness was measured by recording respiratory pres-
sure curves by whole body plethysmography (Buxco
 
Ò
 
, EMKA
Technologies, Paris, France) in response to inhaled methacholine
at 3 
 
3
 
 10
 
2
 
2
 
 M, for 20 s (Aldrich-Chemie, Steinhein, Germany).
This method allows measurements of spontaneous breathing in a
nonrestrained mouse. The airway reactivity was expressed in en-
hanced pause (Penh), a calculated value that correlates with mea-
surement of airway resistance, impedance, and intrapleural pres-
sure in the same mouse. Penh 
 
5
 
 (Te/Tr-1) 
 
3
 
 Pef/Pif (Te,
expiration time; Tr, relaxation time; Pef, peak expiratory flow;
Pif, peak inspiratory flow) (24).
 
Lung Histopathology.
 
Whole lungs were washed with PBS and
inflated by instillation of OCT compound (Tissue-tek
 
Ò
 
; Miles
Inc, Elkhart, IN) via the trachea. The tissue was then removed
and snap-frozen. 8–10 
 
m
 
m cryosections were fixed in methanol
at 20
 
8
 
C for 2.5 min and either stained with Giemsa (Fluka
Chemika, Buchs, Switzerland) for light microscopic examination
or processed for immunohistochemistry. After rehydration in
PBS, sections were incubated for 30 min at 20
 
8
 
C with fluores-
cein-conjugated goat antibodies directed against mouse IgG1 or
IgA (Southern Biotechnology Associates, Inc., Birmingham, AL)
or rat anti–mouse IgE (EM95), anti-FDC (FDC-M1), followed
by fluorescein-conjugated mouse F(ab
 
9
 
)
 
2
 
 anti–rat IgG antibodies
(Southern Biotechnology Associates, Inc.). Germinal center B cells
were identified using biotinylated peanut agglutinin (PNA; Vec-
tor Laboratories, Inc., Burlingame, CA) and plasma cells revealed
using biotinylated Syndecan-1 (PharMigen, San Diego, CA),
each followed by streptavidin–Texas red (Southern Biotechnol-
ogy Associates, Inc.). OVA-specific antibodies were detected us-
ing biotinylated OVA followed by streptavidin–Texas red.
 
Isolation of Lung Cells.
 
3 d after the final provocation, lungs
were perfused with PBS containing 100 U/ml of heparin through
the circulatory system to remove residual blood. Pulmonary and
other regional lymph nodes were dissected away from the lungs
and discarded. The lungs were then enzyme digested with 0.8
mg/ml collagenase IV (Worthington Biochemical, Freehold, NJ)
and DNAse 0.1% (Sigma) in IMDM (GIBCO BRL, Basel, Swit-
zerland). The single cell suspension was then fractionated using a
continuous Percoll gradient. The low buoyant density cells were
Figure 1. OVA-specific Ig serum titers are elevated in OVA sensitized
mice. Serum samples were taken 3 d after the final i.t. challenge. The
NaCl/NaCl group is the sham-treated mice, OVA/NaCl is the group
primed to OVA but given NaCl in the trachea, and OVA/OVA is the
experimental group. Anti-OVA IgE (j), IgG1 (m), IgG2a (n), and
IgG2b (s) were measured by ELISA. The 50% OD maximums were cal-
culated from the titration curves of each sample. 
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Figure 2. Histological evaluation of lungs. (A and B [controls]) Cryosections of lung tissue stained with Giemsa from a mouse primed with OVA but
challenged intratracheally with NaCl (OVA/NaCl). B is a higher magnification of the area indicated by arrows in A. (C and D) Cryosections of tissue
from the lung of a mouse primed and challenged intratracheally with OVA (OVA/OVA). Note the formation of BALT in the vicinity where the pri-
mary bronchus branches (C, arrows). D is a higher magnification of the BALT. Note the change in the epithelium (as compared with B) as well as the
organization of cells in a follicle. (E and F) Cryosections of tissue from lung of another OVA/OVA-treated mouse, this time concentrating on the ap-
pearance of cellular infiltrates within the parenchyma. F is a higher magnification of the infiltrate indicated by arrows in E. Original magnifications, (A,
C, E) 330; (B and D) 3400; (F) 3200. 
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Figure 3.
 
Immunohistochemical evaluation of lungs from OVA/OVA-treated mice. 
 
A–D
 
 reveal the presence of germinal centers and FDCs in the
BALT of OVA/OVA-treated mice. 
 
E–K
 
 focus on the nature of the IgG-, IgA-, and IgE-positive cells within the diffuse infiltrates. 
 
A
 
 shows the double
immunolabeling of FDC-M1-positive cells (
 
green
 
) and PNA binding cells (
 
red
 
). 
 
B
 
 shows only the FDC-M1 positive cells (
 
green
 
) of the same section to
identify more clearly the FDC network within the tissue. 
 
C
 
 again is the single fluorescence of FDC-M1 positive cells (
 
green
 
) in the adjacent section to 
 
A
 
 and
 
B. D
 
 shows by double immunolabeling the binding of biotinylated OVA (revealed by Texas red) to anti-OVA antibodies present on these FDC-M1-pos- 
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itive cells shown in 
 
C
 
 (the green plus red produces yellow). 
 
E–G
 
 show by double immunolabeling the isotype of OVA-binding cells present within the
diffuse infiltrates. Using FITC-conjugated anti-IgG1 (
 
E
 
), anti-IgA (
 
F
 
), or anti-IgE (
 
G
 
), reagents in combination with biotinylated OVA followed by avidin
Texas red revealed the presence of many OVA-specific antibody-positive cells (
 
G
 
, double positive cells are in yellow; 
 
arrows
 
). In an adjacent section to 
 
G
 
(
 
H–K
 
 are all the same section), the presence of plasma cells were confirmed using the rat monoclonal antibody, Syndecan-1, followed by a secondary
FITC-conjugated mouse anti–rat Ig antibody. 
 
H
 
 reveals only the Syndecan-1-positive cells (
 
green
 
), while 
 
I
 
 demonstrates by double immunolabeling (
 
yel-
low
 
) the capacity of many of these cells to bind OVA (using the above mentioned biotinylated OVA and avidin Texas red) indicating their antigen speci-
ficity. 
 
J
 
 and 
 
K
 
 are included as higher magnifications of 
 
H
 
 and 
 
I
 
, respectively, to demonstrate that all OVA binding cells are double positive (
 
orange–yellow
 
),
while some Syndecan-1 positive cells are only single positive. Original magnifications (
 
A
 
 and 
 
B
 
) 
 
3
 
80; (
 
C
 
 and 
 
D
 
) 
 
3
 
200; (
 
E
 
–
 
I
 
) 
 
3
 
50; (
 
J
 
 and 
 
K
 
) 
 
3
 
150.
 
obtained and generally represented between 25 and 50% of the
total population. These cells were then washed and either cul-
tured (3 
 
3
 
 10
 
5
 
 cells per well in 100 
 
m
 
l of IMDM containing 5%
FCS and antibiotics) for 7 d for harvesting of supernatants to de-
tect secreted antibody by an ELISA or prepared for the ELISPOT
assays.
 
ELISPOT Assays.
 
Isolated low buoyant density lung cells
were distributed in triplicate (10
 
5
 
 cells per well in 100 
 
m
 
l of
IMDM containing 5% FCS and antibiotics) into 96-well nitrocel-
lulose-based microplates (Millipore Corp., Bedford, MA) that
were precoated with OVA (20 
 
m
 
g/ml) and incubated at 378C,
5% CO2. The next day, the wells were processed for identifica-
tion of isotype-specific antibodies. After 3 h incubation at 378C
with alkaline phosphatase–conjugated goat anti–mouse IgM,
IgG2a, IgG2b, IgG1, and IgA antibodies (Southern Biotechnol-
ogy Associates, Inc.), the plates were washed and incubated with
the developing substrate 5-bromo-chloro-3-indolphosphate (Boeh-
ringer) in 0.1 M Tris (pH 9.5), 0.1 M NaCl, and 5 mM MgCl.
Results
Immunization of Mice and Serum Antibody Titers. In this
model of lung inflammation, three different treatments were
performed. The experimental group consisted of mice sen-
sitized with injections of OVA either i.p. or s.c. followed
by OVA being placed i.t. As no differences were observed
between these two routes of immunization, these data are
represented together as the OVA/OVA experimental
group. The control immune group, OVA/NaCl, received
i.p. or s.c. injections of OVA followed by NaCl i.t. Finally,
a sham control group, NaCl/NaCl, received NaCl in the
periphery for priming and NaCl i.t.
3 d after the final i.t. challenge, blood was obtained from
mice in each group and the titer of OVA-specific antibody
quantitated (Fig. 1). As expected, the sera of the sham con-
trol mice contained no anti-OVA antibodies, while both
groups of mice primed in the periphery produced signifi-
cant amounts of antigen-specific Ig. The isotypes of these
anti-OVA antibodies were restricted to IgM (data not
shown), IgG1, and IgE, as no IgG2a or IgG2b were de-
tected. These results demonstrate that in the circulation,
anti-OVA antibodies are present in both the immune con-
trol and experimental groups of mice.
Presence of BALT and OVA specific IgG1, IgA, and IgE.
To assess the cellular changes occuring in situ, cryosections
were prepared from the lungs. Fig. 2 shows the differences
observed between lungs from the OVA/NaCl- (A and B)
versus OVA/OVA-treated (C–F) mice. Fig. 2 A is a low
power magnification of a primary bronchus with several
branching points. As seen in the higher magnification in
Fig. 2 B, there is no evidence of cellular infiltrates or epi-
thelial pertubations in the OVA/NaCl controls. In con-
trast, in Fig. 2, C and E, two types of areas are indicated
(arrows) in which cells accumulate after antigen challenge
in the trachea (i.e., OVA/OVA treated). Fig. 2 D, a higher
magnification of C, contains a spherical infiltrate resem-
bling a lymphoid follicle adjacent to the epithelial surface.
Note also the changes occurring at the epithelial surface.
Fig. 2 F, a higher magnification of E, presents a more dif-
fuse infiltrate occuring between blood vessels and airways.
The histology of the NaCl/NaCl-treated group was similar
to the OVA/NaCl group and therefore not shown.
To determine the nature of these infiltrates, immunohis-
tochemistry was performed. The components present in the
follicular-like structures are shown in Fig. 3, A–D and
those of the diffuse aggregates in Fig. 3, E–K. As can be
seen in Fig. 3 A, PNA-binding cells (in red), representative
of germinal center B cells, were present. In addition, FDC-
M1-positive FDCs were identified (green; Fig. 3, A–D). In
the adjacent section to Fig. 3, A and B, the FDC-M1-posi-
tive cells shown as green in C also bore anti-OVA antibod-
ies as revealed using double immunolabeling (D) with bio-
tinylated OVA and avidin–Texas red.
Using anti-Ig isotype-specific reagents, IgG1 (Fig. 3 E),
IgA (F) and IgE (G) positive cells (in green) were detected
within the diffuse aggregates. In addition, double immuno-
labeling with biotinylated OVA (revealed in red by avidin–
Texas red) demonstrated that many of these cells were pro-
ducing anti-OVA antibodies (Fig. 3, E–G; the combination
of OVA and anti-Ig isotype binding produces the yellow).
Figure 4. Quantification of the number of anti-OVA plasma cells iso-
lated from lung. The low buoyant density cells prepared from lungs of
control mice, NaCl/NaCl, OVAip/NaCl, and OVAsc/NaCl (squares)
and of experimental mice, OVAip/OVA, and OVAsc/OVA (diamonds)
were incubated on OVA-coated wells before identification of the Ig iso-
type. Results are plotted as the number of OVA-specific antibody-form-
ing cells (AFC) identified per 105 low buoyant density cells. Each data point
represents the mean of triplicate wells for cells from an individual mouse.2358 Germinal Centers and IgE Production in the Lung
To confirm that these were plasma cells producing antigen-
specific antibody, adjacent sections were incubated with
Syndecan-1 (a monoclonal antibody that recognizes plasma
cells) and biotinylated OVA. Fig. 3 H (and a higher magni-
fication shown in J) revealed that many of the cells were
Syndecan-1 positive (green). Analyzing the green Synde-
can-1 together with the binding of the biotinylated OVA
(red) (Fig. 3 I, and its higher magnification in K) demon-
strated that all the cells binding OVA also were Syndecan-1
positive (orange–yellow color). However, not all Synde-
can-1 positive cells bound OVA (Fig. 3 K, some are green
only), indicating that plasma cells producing antibodies of
other specificities were present. Immunolabeling for CD41
T cells revealed their presence mainly in the diffuse infil-
trates, although a few were scattered within the lymphoid
follicle (micrograph not shown).
Quantitation of Anti-OVA Plasma Cells. To determine the
number of anti-OVA-producing cells present within the
lung, an ELISPOT assay was utilized. The cells were ob-
tained as outlined in Materials and Methods from enzyme-
digested lungs that had been prelavaged with saline. An en-
richment step was introduced in order to concentrate the
frequency of low buoyant density cells using sedimentation
gradients. As can be seen in Fig. 4, only the lungs of mice
that had received OVA in the trachea contained anti-OVA-
forming cells (AFCs). Their presence could not be attrib-
uted to a contaminating contribution from the residual
blood of the lung, as no AFCs were detected in the OVA-
primed but NaCl-challenged mice (OVA/NaCl groups).
The isotypes again were restricted, as only IgM, IgG1, and
IgA were detected and not IgG2a and IgG2b.
Detection of IgE-specific Anti-OVA. Interestingly, only an
occasional anti-OVA-producing cell of the IgE isotype was
detectable by the ELISPOT technique. We reasoned based
on the immunohistology that the number of IgE-secreting
cells was at least 10- to 20-fold lower than IgG1 and might
be at the limit of detection in the assay. To confirm the
production of antigen-specific IgE from the cells of the
lung, the low buoyant density cells were also placed in cul-
ture for 7 d and the supernatants analyzed for the presence
of OVA-specific IgG1 and IgE. As shown in Fig. 5, these
cells producing IgE were present, but at an z10-fold lower
frequency as compared with the IgG1-producing cells.
Airway Hyperresponsiveness in the Lung. To determine
whether the changes occuring histologically were associ-
ated with alterations in airway responsiveness, the sponta-
neous breathing patterns of nonrestrained mice in response
to methacholine were monitored. From the respiratory pres-
sure curves recorded, values for the Penh were calculated
and plotted in Fig. 6. The two graphs shown represent in-
dependent experiments demonstrating that an increase in the
Penh value occurs in OVA/OVA mice after exposure to
nebulized methacholine. Baseline measurements in OVA-
sensitized mice challenged with OVA or NaCl were not
significantly different (Penh 5 1.01 6 0.34, 1.04 6 0.11,
n 5 4, and 0.51 6 0.11, 0.61 6 0.11, n 5 6, respectively).
After methacholine aerosol, Penh values showed a 3.4 (n 5
4) and 5.2 (n 5 6) fold increase in OVA/OVA mice. This
is in contrast with the OVA/NaCl-treated mice for which
the Penh values remained at baseline level after methacho-
line aerosol (Penh 5 1.24 6 0.13, n 5 4 and 0.96 6 0.43,
n 5 6). These experiments documented that an increase in
airway responsiveness occurs under conditions where ger-
minal centers are also induced to form.
Discussion
The findings presented here demonstrate that in response
to an airway antigenic challenge, local histological changes
occur that have a dramatic potential for exacerbating in-
flammatory processes. This includes the formation of ger-
minal centers with antigen-retaining FDC as well as cellu-
lar infiltrates containing significant numbers of plasma cells
(Fig. 3). The demonstration of BALT with germinal cen-
ters, which are sites of B cell Ig class switch and affinity
maturation, provides evidence for local B cell activation
and differentiation. The use of reagents, such as Syndecan-1
(Fig. 3), and the quantitation of isotype specific Ig by anti-
body capture assays (Figs. 4 and 5) confirm the presence in
Figure 5. Anti-OVA titers in supernatants of cells isolated from lung
tissue. The same low buoyant density cells obtained in Fig. 4 were cul-
tured for 7 d and the supernatants harvested. OVA-specific IgG1 and IgE
titers were measured by ELISA. As in Fig. 4, square symbols represent ti-
ters of Igs detected in cell supernatants prepared from lungs of control
mice, NaCl/NaCl, OVAip/NaCl, and OVAsc/NaCl, and the diamond
symbols represent Ig titers detected in cell supernatants prepared from
lungs of experimental mice, OVAip/OVA, and OVAsc/OVA. The re-
sults represent the mean of triplicate wells from an individual mouse.
Figure 6. Increased airway responsiveness to methacholine in OVA-
sensitized/OVA-challenged mice. Airway reactivity in response to meth-
acholine (3 3 1022 M, for 20 s) was measured by whole-body plethys-
mography (BuxcoÒ) in the control group OVA/NaCl (squares) versus the
experimental group OVA/OVA (diamonds). This method allows mea-
surements of spontaneous breathing in a nonanesthetized mice by record-
ing respiratory pressure curves before (open symbols) and after (closed sym-
bols) methacholine inhalation. From the curves, values for the enhanced
pause (Penh) are calculated and used as an index of airway responsiveness.2359 Chvatchko et al.
the lung parenchyma of plasma cells secreting IgG1, IgA,
and IgE. Since cross-linking the high affinity IgE receptor
via allergen triggers activation in many of the cell types re-
sponsible for inflammatory processes, these observations
suggest a mechanism for promoting the ultimately detri-
mental extent of the reaction to an airborne protein.
Many studies have concentrated on the T cell compo-
nent of lung inflammation (25, 26). These data demonstrate
that there is a propensity to develop cells that secrete Th2
cytokines, such as IL-4 (27–29). This pattern of cytokine
production also promotes T cell help for B cells (30, 31)
and would be in line with our findings of local induction of
B cell activation and differentiation towards IgG1 and IgE
production. The ability to define plasma cells using Synde-
can-1 proved to be an essential tool for demonstrating that
the IgE-positive cells detected in the lung, reported here by
us and elsewhere by others (32), are antibody-producing
plasma cells and not IgE-binding inflammatory cells, which
are also seen in the sections. Our demonstration of BALT
containing germinal centers furthermore provides evidence
of a local microenvironment for the preplasma cell induction.
The experimental murine model of lung inflammation
presented here appears to be a reasonable choice, as re-
cently Blyth and colleagues (1) have shown that it mimics
many characteristic features found in asthma. Eosinophilia,
activation of macrophages, recruitment of lymphocytes,
neutrophils and monocytes, and changes in airway epithe-
lium, including goblet cell hyperplasia with concurrent ap-
pearance of mucus plugs, occur in the lung. In addition,
the T cells that infiltrate the lung are antigen specific and
produce IL-4 when restimulated in vitro (Chvatchko, Y., T.
Coyle, M. Kosco-Vilbois, J.P. Aubry, and J.Y. Bonnefoy,
manuscript in preparation). In the present study, we were
also able to document the development of airway hyperre-
sponsiveness. As these features correlate well with the com-
ponents of allergic asthma ascribed to patients, our observa-
tions of germinal center development in this experimental
model are significant. IgE being a major mediator of in-
flammatory processes and germinal centers being a com-
mon site for Ig class switch imply a potential pathologic
role for the formation of these microenvironments locally.
Further identification of the factors controlling responses
occuring within BALT and germinal centers may prove an
effective approach for reducing the incidence of asthmatic
attacks in airway-sensitized individuals.
The formation of BALT and its relationship to inflam-
matory processes has been a matter of speculation. It ap-
pears that in certain species, such as our observations pre-
sented here for mice and from other investigators concerning
human lungs, report BALT is induced upon challenge with
pathogens (9, 33, 34). While some argue the significance of
BALT in adult tissue (10), investigators have clearly shown
that in infants and children, BALT can more often be de-
tected and again appears dependent upon antigenic stimu-
lation (13, 35). Slavin and colleagues (36), for example,
observed BALT in the lung biopsies obtained from a 13-yr-old
patient suffering with allergic bronchopulmonary aspergillosis.
Not long ago, after reviewing the current status of the field,
Holt (37) suggested that protocols to induce immune devi-
ation in children along mucosal surfaces may be an effective
means to lessen the incidence of atopic allergy and asthma.
In light of the fact that germinal centers form in mice ren-
dered deficient for IL-4 (38) and deviate the production of
isotypes towards IgG2a and IgG2b instead of IgG1 and IgE
(39), such a strategy would appear reasonable. The protec-
tive component of mucosal germinal center responses
would be maintained, while the arm contributing to the
pathogenesis, i.e., IgE production, would be eliminated. The
ability to skew the T cell response away from a Th2 pheno-
type is currently an intensely pursued area and, using the
model presented here, we are also attempting to determine
how this could be achieved locally in the BALT.
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